Penn Medicine New Horizons in Nephrology Glomerular Disease Webinar

The Penn Medicine New Horizons in Nephrology: Glomerular Disease Webinar 2026 is a focused educational program designed to provide healthcare professionals with the latest clinical updates on the pathophysiology, diagnosis, and management of complex glomerular diseases. This webinar explores the evolving role of B-cell biology in kidney disease and highlights emerging therapeutic approaches that are reshaping treatment strategies across a range of immune-mediated glomerular disorders.

Through evidence-based presentations and case-based learning, participants will gain a deeper understanding of how B-cell pathways contribute to disease progression and how targeted therapies can be used to improve patient outcomes. The program emphasizes practical clinical applications, current research findings, and advances in precision medicine for glomerular disease management.

---

Learning Objectives

Upon completion of this program, participants will be able to:

• Analyze the physiology and clinical significance of the B-cell pathway in glomerular diseases.
• Evaluate current monitoring strategies for patients receiving B-cell-targeted therapies.
• Assess the efficacy and clinical application of B-cell-targeting treatments in IgA nephropathy.
• Implement evidence-based therapeutic approaches for the management of lupus nephritis.
• Review emerging treatment strategies for membranous nephropathy and primary podocytopathies.
• Apply advanced diagnostic and therapeutic principles to complex clinical cases.
• Incorporate evolving evidence into clinical decision-making to optimize patient outcomes.

---

Target Audience

This program is intended for:

• Nephrologists
• Internal Medicine Physicians
• Advanced Practice Providers
• Nephrology Fellows and Trainees
• Healthcare professionals involved in the diagnosis and treatment of glomerular diseases

---

Program Highlights

Understanding the B-Cell Pathway in Glomerular Disease

Explore the fundamental role of B cells in immune-mediated kidney diseases, including their involvement in antibody production, antigen presentation, cytokine signaling, and renal inflammation. Learn how advances in immunology are shaping new treatment opportunities in nephrology.

Advances in B-Cell-Targeted Therapies

Review the latest developments in targeted therapies designed to modulate B-cell activity and reduce pathogenic immune responses. Gain insights into emerging therapeutic strategies and their impact on disease remission, treatment durability, and patient safety.

B-Cell Targeting in IgA Nephropathy

Examine current evidence supporting B-cell-targeted interventions in IgA nephropathy and discuss evolving approaches to disease management, monitoring, and long-term care.

B-Cell Targeting in Lupus Nephritis

Explore updated treatment paradigms for lupus nephritis, including the use of targeted biologic therapies and evidence-based strategies for improving renal outcomes.

B-Cell Targeting in Membranous Nephropathy and Primary Podocytopathies

Review contemporary management approaches for membranous nephropathy and primary podocytopathies, with a focus on novel therapies and individualized treatment planning.

Case-Based Clinical Learning

Apply key concepts through interactive case presentations that illustrate real-world challenges in diagnosis, treatment selection, monitoring, and long-term disease management.

Expert Discussion and Interactive Q&A

Participate in panel discussions and question-and-answer sessions designed to address practical clinical challenges and emerging topics in glomerular disease care.

---

Topics Covered

• Physiology of the B-Cell Pathway
• Monitoring and Targeting B-Cell Activity
• B-Cell Targeting in IgA Nephropathy
• B-Cell Targeting in Lupus Nephritis
• B-Cell Targeting in Membranous Nephropathy
• Primary Podocytopathies
• Advances in Immune-Mediated Kidney Disease Management
• Emerging Biologic and Precision Therapies
• Case Presentation: Membranous Nephropathy
• Case Presentation: Lupus Nephritis
• Case Presentation: IgA Nephropathy
• Clinical Decision-Making in Glomerular Disease
• Interactive Panel Discussions and Q&A Sessions

---

Clinical Relevance

B cells play a critical role in the development and progression of many glomerular diseases through mechanisms involving autoantibody production, immune complex formation, and inflammatory signaling pathways. Conditions such as lupus nephritis, membranous nephropathy, IgA nephropathy, and ANCA-associated vasculitis are strongly influenced by B-cell-mediated immune responses, making these pathways important therapeutic targets.

Recent advances in B-cell-directed therapies have expanded treatment options beyond traditional immunosuppression, offering clinicians new opportunities to achieve sustained disease control while minimizing treatment-related complications. As the therapeutic landscape continues to evolve, understanding the mechanisms, efficacy, and safety considerations of these treatments is essential for delivering optimal patient care.

---

Why Attend?

This program offers a valuable opportunity to stay current with the rapidly evolving field of glomerular disease treatment. Participants will gain actionable insights into B-cell-targeted therapies, emerging clinical evidence, advanced treatment strategies, and real-world case management approaches that can be immediately integrated into clinical practice to improve patient outcomes.